Attention deficit hyperactivity disorder (ADHD) is the most common disability diagnosis in children globally. It's estimated ...

Co-occurring ADHD and substance use create unique challenges. The latest research shows what effective treatment really requires.

From December 1, specialist general practitioners will have the ability to diagnose adults with ADHD and prescribe medication ...

Groundbreaking research has uncovered a set of just three gene variants that can increase the likelihood of attention-deficit ...

A new study suggests the connection between Attention-Deficit/Hyperactivity Disorder (ADHD) and the body’s primary stress ...

Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded ...

Pfizer (PFE) stock is in focus as the firm joins Tris Pharma to settle a lawsuit over supplying an adulterated ADHD drug to ...

Two manufacturers have issued recalls for generic Adderall, one over unknown impurities and the other over bottle mislabeling ...

Pfizer Inc. and Tris Pharma Inc. will pay the state of Texas $41.5 million to settle claims that it allegedly provided ...

Some people refer to attention-deficit/hyperactivity disorder as "a superpower" while others describe their ADHD symptoms as debilitating. Can both be true?

Attention deficit hyperactivity disorder (ADHD) is the most common disability diagnosis in children globally. It's estimated to affect around 8% ...

Powerful psychotropic drugs are often the next step, even though their combined effects in young children haven’t been ...